Fig. 3
From: Plasma TIMP-1 as a sex-specific biomarker for acute lung injury
Plasma TIMP-1 levels and 90-day mortality. A ROC curve for TIMP-1 concentration and 90-day mortality of all ARDS patients (survivors = 74; non-survivors = 26). B ROC curve for TIMP-1 concentration and 90-day mortality of male patients (survivors = 38; non-survivors = 16). C ROC curve for TIMP-1 concentration and 90-day mortality of female patients (survivors = 36; non-survivors = 10). D Sex divided TIMP-1 level comparison in survivors (females n = 36; males n = 38), and non-survivors at 90 days (females n = 10; males n = 16). E Kaplan–Meier survival curves for ARDS female patients censored at 90 days